Description of Intelgenx Technologies's Business Segments
Intelgenx Technologies Corp is a pharmaceutical company that specializes in the development of novel drug delivery systems and formulations. The company focuses particularly on the research and development of oral drug delivery technologies designed for a range of applications, including allowing for the improved bioavailability of drugs and enhancing patient compliance.
Segments
1. Pharmaceutical Development: Intelgenx operates primarily in the pharmaceutical sector, providing advanced drug formulation technologies. This segment emphasizes creating innovative drug delivery methods, leveraging unique platforms to enhance the effectiveness and usability of medications.
2. Partnerships and Collaborations: The company engages in strategic partnerships with other biotechnology and pharmaceutical companies. These collaborations typically focus on developing and commercializing new drug delivery systems, expanding their reach and expertise in various therapeutic areas.
3. Research and Development: Intelgenx invests significantly in R&D to explore new drug delivery technologies and improve existing formulations. This segment emphasizes innovation and aims to create medically beneficial products aimed at specific health conditions.
Products
Intelgenxs product offerings primarily revolve around their proprietary drug delivery systems. These include:
1. Vividrin®: An oral film formulation designed for the effective delivery of active pharmaceutical ingredients (API) via the oral cavity, providing rapid onset of action.
2. Intellitabâ„¢: A patented platform for oral delivery systems that allows for controlled release properties, enhancing bioavailability and patient compliance.
3. Oral Thin Film Products: These include products designed to dissolve quickly in the mouth, providing convenience and improved delivery for active ingredients that may otherwise be poorly absorbed in the gastrointestinal tract.
4. Montelukast for Allergies: A formulation designed for treating allergic rhinitis through a novel delivery method that offers ease of use and improved patient adherence compared to traditional formats.
Services
Intelgenx also offers a range of services, focusing on their expertise in drug formulation and development:
1. Formulation Development Services: The company provides services ranging from initial formulation development to clinical trial support. This includes assistance with dosage form design, stability testing, and scaling up for commercial production.
2. Contract Manufacturing: Intelgenx may offer contract manufacturing services that allow pharmaceutical companies to utilize their advanced technologies for their products. This includes producing the novel drug delivery systems they have developed.
3. Regulatory Support Services: The company navigates the complex regulatory landscape of drug approval processes, offering expertise to partners in compiling necessary documentation and submissions to gain regulatory approval from government agencies.
4. Consultation and Technical Services: Intelgenx provides consultation services to other pharmaceutical companies focused on improving product efficacy and compliance through innovative delivery systems. This includes technical support in the areas of formulation, stability, and delivery methods.
Through these segments, products, and services, Intelgenx Technologies Corp aims to facilitate the development of effective medication delivery systems that cater to the evolving needs of the healthcare sector, ultimately enhancing patient outcomes and satisfaction.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
